Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FR8UN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,946
Award facts
- Contract value 100% obligated
- $8,946.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $8,946.22 delivery order (Contract No. 4570268741) to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injector pens. This competitively awarded, firm fixed-price order is scheduled for completion by December 15, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical prime vendor agreement valued through December 2026 that enables AmerisourceBergen to supply a broad range of medications and medical commodities to support military healthcare operations globally.
This award reflects AmerisourceBergen's established role as a critical pharmaceutical distributor within the federal medical supply chain, particularly serving the Defense Health Agency and other military healthcare systems. Repatha is a cardiovascular medication used for cholesterol management, consistent with the company's extensive portfolio of specialty pharmaceuticals and brand-name drugs delivered through DLA contracts. As a non-set-aside award issued through open competition, this delivery order demonstrates AmerisourceBergen's continued capability to fulfill federal medical procurement requirements while supporting the military healthcare system's pharmaceutical needs.
Quick answers
Who was awarded contract SPE2DR26FR8UN?
SPE2DR26FR8UN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26FR8UN worth?
The government has obligated $8,946 on SPE2DR26FR8UN.
Is contract SPE2DR26FR8UN an order under another contract?
Yes. SPE2DR26FR8UN is a delivery order under SPE2DR25D3018, an indefinite delivery contract.
Was contract SPE2DR26FR8UN competed?
The extent of competition for SPE2DR26FR8UN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award